These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 8129567)
1. Observation of the effect of low oral doses of human leukocytic interferon alpha in children with chronic HBV infection and impaired immune response. Ratajczak B Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):237-40. PubMed ID: 8129567 [No Abstract] [Full Text] [Related]
2. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally. Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy of natural human interferon alpha lozenges on the clinical course of childhood neoplasia and in chronic hepatitis B virus infection in patients who were successfully treated for pediatric malignancies. Balcerska A; Bohdan Z; Drozyńska E; Kozielska E; Szarszewski A; Georgiades JA Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):221-7. PubMed ID: 8129565 [TBL] [Abstract][Full Text] [Related]
4. [The treatment of different forms of B and delta hepatitis with interferon preparations]. Botsvadze ESh; Kuznetsov VP; Aleksishvili MM; Gogichaĭshvili ShSh Ter Arkh; 1991; 63(11):61-3. PubMed ID: 1810067 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients. Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152 [TBL] [Abstract][Full Text] [Related]
6. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317 [TBL] [Abstract][Full Text] [Related]
7. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Marinos G; Naoumov NV; Williams R Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365 [TBL] [Abstract][Full Text] [Related]
8. [Interferon alpha in the treatment of chronic hepatitis B in children]. Wysocki J; Słuzewski W; Kowala-Piaskowska A; Biczysko W Pediatr Pol; 1995 May; 70(5):407-11. PubMed ID: 8692595 [TBL] [Abstract][Full Text] [Related]
9. Natural human interferon alpha given orally has different effects on patients with distinct forms of chronic viral hepatitis B. Georgiades JA; Caban J; Zyrkowska-Bieda T; Zejc M; Jonas-Skulina U; Cieśla A Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):187-94. PubMed ID: 8915525 [TBL] [Abstract][Full Text] [Related]
10. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320 [TBL] [Abstract][Full Text] [Related]
11. High-dose interferon results in high HBsAg seroclearance in children with chronic hepatitis B infection. Ertem D; Acar Y; Kotiloğlu Karaa E; Pehlivanoğlu E Turk J Pediatr; 2003; 45(2):123-8. PubMed ID: 12921298 [TBL] [Abstract][Full Text] [Related]
12. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial. Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. Iorio R; Giannattasio A; Cirillo F; D' Alessandro L; Vegnente A Clin Infect Dis; 2007 Oct; 45(8):943-9. PubMed ID: 17879906 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Kansu A; Kuloğlu Z; Demirçeken F; Girgin N Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973 [TBL] [Abstract][Full Text] [Related]
15. Unexpected protection from infection by two booster hepatitis B virus vaccination in children with acute lymphoblastic leukemia. Yetgin S; Tavil B; Aytac S; Kuskonmaz B; Kanra G Leuk Res; 2007 Apr; 31(4):493-6. PubMed ID: 16930691 [TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis]. Zwolińska D; Inglot M; Makulska I; Gładysz A; Szprynger K; Szczepańska M; Pietrzyk J; Zachwieja K; Zurowska A; Zachwieja J; Rajkowski T; Jobs K; Latoszyńska J; Jander A Pol Merkur Lekarski; 2001 Apr; 10(58):267-70. PubMed ID: 11434173 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B in children. Broderick AL; Jonas MM Semin Liver Dis; 2003 Feb; 23(1):59-68. PubMed ID: 12616451 [TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up. Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847 [TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha treatment of children with chronic hepatitis D virus infection: the Greek experience. Dalekos GN; Galanakis E; Zervou E; Tzoufi M; Lapatsanis PD; Tsianos EV Hepatogastroenterology; 2000; 47(34):1072-6. PubMed ID: 11020882 [TBL] [Abstract][Full Text] [Related]